129 related articles for article (PubMed ID: 16525664)
1. Recurrence and 5-FU sensitivity of stage I/II node-negative breast, lung, or gastric cancer with occult neoplastic cells in lymph node sinuses.
Mukai M; Sato S; Tajima T; Ninomiya H; Wakui K; Komatsu N; Tsuchiya K; Nakasaki H; Makuuchi H
Oncol Rep; 2006 Apr; 15(4):815-20. PubMed ID: 16525664
[TBL] [Abstract][Full Text] [Related]
2. Recurrence and 5-FU sensitivity of stage II/III node-positive gastric cancer with occult neoplastic cells in lymph node sinuses.
Mukai M; Tajima T; Sato S; Ninomiya H; Wakui K; Komatsu N; Tsuchiya K; Nakasaki H; Makuuchi H
Oncol Rep; 2005 Dec; 14(6):1505-10. PubMed ID: 16273246
[TBL] [Abstract][Full Text] [Related]
3. Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses.
Mukai M; Sato S; Ninomiya H; Wakui K; Komatsu N; Tsuchiya K; Nakasaki H; Makuuchi H
Oncol Rep; 2005 Nov; 14(5):1165-9. PubMed ID: 16211280
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and 5-FU sensitivity of stage II/Dukes' B colorectal cancer with occult neoplastic cells in lymph node sinuses.
Mukai M; Sato S; Ninomiya H; Wakui K; Komatsu N; Tsuchiya K; Nakasaki H; Makuuchi H
Oncol Rep; 2005 Nov; 14(5):1171-6. PubMed ID: 16211281
[TBL] [Abstract][Full Text] [Related]
5. Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer.
Mukai M; Sato S; Nakasaki H; Tajima T; Saito Y; Nishiumi N; Iwasaki M; Tokuda Y; Ogoshi K; Inoue H; Makuuchi H
Oncol Rep; 2004 Jan; 11(1):81-4. PubMed ID: 14654906
[TBL] [Abstract][Full Text] [Related]
6. Prospective study on the recurrence/metastasis of stage II/III colorectal cancer and gastric cancer associated with occult neoplastic cells in lymph node sinuses: three-year interim results.
Mukai M; Tajima T; Sato S; Ninomiya H; Wakui K; Komatsu N; Tsuchiya K; Nakasaki H; Makuuchi H
Oncol Rep; 2006 Aug; 16(2):405-10. PubMed ID: 16820923
[TBL] [Abstract][Full Text] [Related]
7. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
Huang CL; Yokomise H; Kobayashi S; Fukushima M; Hitomi S; Wada H
Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
[TBL] [Abstract][Full Text] [Related]
9. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer.
Shintani Y; Ohta M; Hirabayashi H; Tanaka H; Iuchi K; Nakagawa K; Maeda H; Kido T; Miyoshi S; Matsuda H
Lung Cancer; 2004 Aug; 45(2):189-96. PubMed ID: 15246190
[TBL] [Abstract][Full Text] [Related]
13. Predicting the recurrence/metastasis of stage II and III breast cancer with lymph node metastasis.
Mukai M; Sato S; Kimura T; Komatsu N; Ninomiya H; Nakasaki H; Ogoshi K; Makuuchi H
Oncol Rep; 2004 Aug; 12(2):303-6. PubMed ID: 15254693
[TBL] [Abstract][Full Text] [Related]
14. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
Hisamitsu K; Tsujitani S; Yamaguchi K; Fukuda K; Konishi I; Kaibara N
Anticancer Res; 2004; 24(4):2495-501. PubMed ID: 15330204
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to CPT-11 and platinum derivatives of stage I/II node-negative breast, lung, and gastric cancer with occult neoplastic cells in lymph node sinuses.
Mukai M; Sato S; Ninomiya H; Wakui K; Komatsu N; Matsui N; Nakamura M; Nakasaki H; Makuuchi H
Oncol Rep; 2007 Jul; 18(1):33-9. PubMed ID: 17549342
[TBL] [Abstract][Full Text] [Related]
19. Predicting the recurrence/metastasis of stage I and II breast cancer without lymph node metastasis.
Mukai M; Sato S; Kimura T; Komatsu N; Ninomiya H; Nakasaki H; Ogoshi K; Makuuchi H
Oncol Rep; 2004 Oct; 12(4):745-8. PubMed ID: 15375494
[TBL] [Abstract][Full Text] [Related]
20. Criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis.
Mukai M; Sato S; Kimura T; Komatsu N; Ninomiya H; Nakasaki H; Ogoshi K; Makuuchi H
Oncol Rep; 2004 Jul; 12(1):59-62. PubMed ID: 15201959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
